Recursion Pharmaceuticals Inc
NASDAQ:RXRX

Watchlist Manager
Recursion Pharmaceuticals Inc Logo
Recursion Pharmaceuticals Inc
NASDAQ:RXRX
Watchlist
Price: 6.03 USD -0.99%
Market Cap: 2.3B USD
Have any thoughts about
Recursion Pharmaceuticals Inc?
Write Note

Balance Sheet

Balance Sheet Decomposition
Recursion Pharmaceuticals Inc

Current Assets 474.2m
Cash & Short-Term Investments 427.6m
Receivables 2.3m
Other Current Assets 44.3m
Non-Current Assets 252.3m
PP&E 159.2m
Intangibles 86.1m
Other Non-Current Assets 7m
Current Liabilities 108.9m
Accounts Payable 2.3m
Accrued Liabilities 48.8m
Other Current Liabilities 57.8m
Non-Current Liabilities 93.1m
Long-Term Debt 20.5m
Other Non-Current Liabilities 72.5m

Balance Sheet
Recursion Pharmaceuticals Inc

Rotate your device to view
Balance Sheet
Currency: USD
Dec-2019 Dec-2020 Dec-2021 Dec-2022 Dec-2023
Assets
Cash & Cash Equivalents
70
262
285
550
392
Cash Equivalents
70
262
285
550
392
Short-Term Investments
0
0
231
0
0
Total Receivables
0
0
9
3
3
Accounts Receivables
0
0
0
0
0
Other Receivables
0
0
9
3
0
Other Current Assets
6
4
9
17
43
Total Current Assets
76
266
535
570
438
PP&E Net
24
26
65
121
120
PP&E Gross
24
26
65
121
120
Accumulated Depreciation
6
10
19
30
45
Intangible Assets
0
2
1
1
36
Goodwill
0
1
1
1
52
Other Long-Term Assets
1
4
9
8
7
Other Assets
0
1
1
1
52
Total Assets
101
N/A
299
+194%
610
+104%
701
+15%
654
-7%
Liabilities
Accounts Payable
1
1
3
5
4
Accrued Liabilities
5
11
34
39
53
Short-Term Debt
0
0
0
0
0
Current Portion of Long-Term Debt
0
1
0
0
0
Other Current Liabilities
0
10
10
57
36
Total Current Liabilities
7
23
47
100
93
Long-Term Debt
12
11
1
1
1
Deferred Income Tax
0
0
0
0
1
Other Liabilities
6
22
20
115
95
Total Liabilities
25
N/A
57
+130%
67
+19%
216
+220%
190
-12%
Equity
Common Stock
201
448
0
0
0
Retained Earnings
127
214
400
640
968
Additional Paid In Capital
2
7
943
1 125
1 431
Other Equity
0
0
0
0
0
Total Equity
77
N/A
242
+215%
543
+124%
486
-11%
463
-5%
Total Liabilities & Equity
101
N/A
299
+194%
610
+104%
701
+15%
654
-7%
Shares Outstanding
Common Shares Outstanding
162
162
170
191
234

See Also

Discover More